Sanara MedTech Announces Board & Executive Changes
Ticker: SMTI · Form: 8-K · Filed: Sep 2, 2025 · CIK: 714256
| Field | Detail |
|---|---|
| Company | Sanara Medtech Inc. (SMTI) |
| Form Type | 8-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.001, $90,000, $40,000, $100,000, $600,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
Sanara MedTech shakes up board and exec pay; new directors in, some officers out.
AI Summary
Sanara MedTech Inc. announced on August 27, 2025, changes in its board of directors and executive compensation. The filing details the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for key personnel. This report also includes financial statements and exhibits, along with a Regulation FD disclosure.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect company strategy and stability.
Key Players & Entities
- Sanara MedTech Inc. (company) — Registrant
- August 27, 2025 (date) — Date of earliest event reported
- Texas (location) — State of incorporation
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of certain officers and directors, but does not specify the exact roles in the provided text.
Who are the newly elected directors?
The filing mentions the election of new directors but does not list their names in the provided text.
What are the key changes in compensatory arrangements for officers?
The filing notes adjustments to compensatory arrangements for certain officers, but the specifics are not detailed in the provided text.
What is the significance of the Regulation FD Disclosure mentioned?
A Regulation FD Disclosure ensures that material non-public information is broadly disseminated to the public, preventing selective disclosure.
What financial statements and exhibits are included with this filing?
The filing states that Financial Statements and Exhibits are included, but the specific content of these exhibits is not detailed in the provided text.
Filing Stats: 2,020 words · 8 min read · ~7 pages · Grade level 11.1 · Accepted 2025-09-02 16:43:22
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value SMTI The Nasdaq Capital M
- $90,000 — i) shares of restricted stock valued at $90,000 and (ii) $40,000 in cash. Mr. Nixon wil
- $40,000 — ricted stock valued at $90,000 and (ii) $40,000 in cash. Mr. Nixon will also be entitle
- $100,000 — d to receive an annual cash retainer of $100,000 for his service as Executive Chairman o
- $600,000 — at Mr. Yon's annual base salary will be $600,000, less applicable taxes and other legal
- $1.0 m — estricted stock having a value equal to $1.0 million, with the number of shares of res
Filing Documents
- form8-k.htm (8-K) — 57KB
- ex10-1.htm (EX-10.1) — 141KB
- ex99-1.htm (EX-99.1) — 17KB
- ex99-1_001.jpg (GRAPHIC) — 11KB
- 0001493152-25-012560.txt ( ) — 436KB
- smti-20250827.xsd (EX-101.SCH) — 3KB
- smti-20250827_lab.xml (EX-101.LAB) — 33KB
- smti-20250827_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 2, 2025 Sanara MedTech Inc . By: /s/ Ronald T. Nixon Name: Ronald T. Nixon Title: Executive Chairman and Chief Executive Officer